Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$600K Sell
1,656
-122
-7% -$41.8K 0.1% 139
2026
Q1
$626K Buy
1,778
+10
+0.6% +$3.56K 0.15% 95
2025
Q4
$579K Buy
+1,768
New +$561K 0.14% 101

Other funds holding AMGN

COFG Advisors's AMGN Position: Q2 2026 in Review

COFG Advisors reduced its Amgen (AMGN) stake by 6.9% in Q2 2026, selling an estimated $41.8K and leaving 1,656 shares worth $600K. The position accounts for 0.1% of the portfolio, ranked #139.

COFG Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $626K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • COFG Advisors held 1,656 shares of Amgen worth $600K as of Q2 2026.
  • COFG Advisors sold 122 Amgen shares in Q2 2026, an estimated $41.8K.
  • Amgen made up 0.1% of COFG Advisors's portfolio in Q2 2026, its #139 holding.
  • COFG Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • COFG Advisors's Amgen position peaked at $626K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on COFG Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.